High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension;Alta prevalencia de hiperaldosteronismo primario no diagnosticado en hipertensos catalogados como esenciales

Revista Medica de Chile

Volumn 127, Issue 7, 1999, Pages 800-806

  Mosso G, Lorena ^a   Fardella B, Carlos ^a   Montero L, Joaquín ^a   Rojas V, Paulina ^a   Sánchez F, Olga ^a   Rojas V, Verónica ^a   Rojas O, Auristela ^a   Huete G, Alvaro ^a   Soto M, Julia ^a   Foradori C, Arnaldo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Aldosterone; Hyperaldosteronison; Hypertension; Hypokalemia; Renin

Indexed keywords

ALDOSTERONE; RENIN;

ARTICLE; BLOOD; COMORBIDITY; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; METABOLISM; MIDDLE AGED; PREVALENCE;

ALDOSTERONE; COMORBIDITY; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; MIDDLE AGED; PREVALENCE; RENIN;

EID: 0033155140     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. DANNENBERG AL, GARRISON RJ, KANNEL WB. Incidence of hypertension in the Framingham study. Am J Public Health 1988; 78: 676-9.
2. BERRÍOS X, JADUE L, ZENTENO J, ROSS MI, RODRÍGUEZ H. Enfermedades crónicas del adulto. Estudio de algunos factores de riesgo en población general urbana de la Región Metropolitana, 1986-1987. Rev Méd Chile 1990; 118: 1042-3.
3. The Fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1995; 153: 154-83.
4. CONN JW, COHEN EL, ROVNER DR, NESBIT RM. Normokalemic primary aldosteronism. A detectable cause of curable "essential" hypertension. JAMA 1965; 193: 200-6.
5. TUCKER RM, LABARTHE DR. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 to 1975. Mayo Clin Proc 1977; 52: 549-55.
6. GORDON RD, ZLESAK MD, TUNNY TJ, STOWASSER M, KLEMM SA. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993; 20: 296-8.
7. LINS PE, ADAMSON U. Plasma aldosterone-plasma renin activity ratio: a simple test for primary aldosteronism. Acta Endocrinolol 1986; 113: 564-9.
8. BLUMENFELD JD, SEALEY JE, SCHLUSSEL Y, VAUGHAN ED JR, SOS TA, ATLAS SA, MÜLLER FB, ACEVEDO R, ULICK S, LARAGH JH. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877-85.
9. MCKENNA TJ, SEQUEIRA SJ, HEFFERNAN A, CHAMBERS J, CUNNINGHAM S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952-7.
10. GORDON R. Mineralocorticoid hypertension. Lancet 1994; 344: 240-3.
11. KEETON TK, CAMPBELL WB. The pharmacologic alteration of renin release. Pharmacol Rev 1980; 32: 91.
12. BELLISANT E, ANNANE D, THUILEZ C, GIUDICELLI JF. Comparison of the effect of dilevalol and propanolol on sistemic and regional haemodynamics in healthy volunteers at rest and during exercise. Eur J Clin Pharmacol 1994; 47: 39-47.
13. PATRONO C, PUGLIESE F, CIABATTONI G, PATRIGNANI P, MASERI A, CHIERCHIA S, PESKAR BA, CINOTTI GA, SIMONETTI BM, PIERUCCI A. Evidence for direct stimulating effect of prostacyclin on renin release in man. J Clin Invest 1982; 69: 1: 231.
14. GERBER J, OLSON RD, NIES AS. Interrelationship between prostaglandins and renin release. Kidney Int 1981; 19: 816.
15. MENARD J, CORVOL P. Mesure de l'activite rénine plasmatique de l'homme par le dosage radioimmunologique de l'angiotensine I. Techn. Radioimmunol, Paris, Inserm 1972; 459.
16. MONTERO J, SOTO J, FARDELLA C, FORADORI A, VALDÉS G. Medición de la actividad de renina plasmática a niveles bajos, optimización del método. Rev Méd Chile 1998; 126: 151-4.
17. LICHFIELD W. Primary aldosteronism. In Clinical Endocrinology Update. 1997; 241-52.
18. STREETEEN A. Fludocortisone suppression test. Am J Med 1979; 67: 403.
19. NEW MI, PETERSON RE. A new form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1967; 27: 300-5.
20. DLUHY R, LIFTON R. Glucocorticoid-remediable aldosteronism (GRA): Diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 1995; 60: 48-51.
21. LICHFIELD W, NEW M. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. JCEM 1997; 82: 3570-3.
22. KOMIYA I, YAMADA T, AIZAWA T, TAKASU N, NIWA A, MAYURAMA Y, OGAWA A. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Cardiology 1991; 78: 99-110.
23. BROWN MA, CRAMP HA, ZAMMIT VC, WHITWORTH JA. Primary hyperaldosteronism: a missed diagnosis in "essential hypertensives"? Aust NZ J Med 1996; 26: 533-8.
24. DLUHY R, LIFTON R. Glucocorticoid-remediable aldosteronism (GRA): Diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 1995; 60: 48-51.
25. LIFTON R, DLUHY RG, POWERS M, RICH GM, COOK S, ULICK S, LALOUEL JM. A chimaeric 11B-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 335: 269-5.
26. PASCOE L, CURNOW K, SLUTKER L, CONNEL JMC, SPEISER PW, NEW MI, WHITE PW. Glucocorticoid-suppresible hyperaldosteronism results from hybrid genes created by unequal crossover between CYP11B1 and CYP11B2. Proc Natl Acad Sci (USA) 1992; 89: 8327-31.
27. MONTERO J, FARDELLA CE, MOSSO L. Hipertensión arterial tratable con glucocorticoides: comunicación de un caso. Rev Méd Chile 1997; 125: 1361-5.
28. FARDELLA CE, RODRÍGUEZ H, MONTERO J, ZHANG G, VIGNOLO P, ROJAS A, VILLARROEL L, MILLER WL. Genetic variation in P450c11AS in Chilean patients with essential hypertension. JCEM 1996; 81: 4347-51.
29. FARDELLA CE, RODRÍGUEZ H, HUM DW, MELLON SH, MILLER WL. Artificial mutation in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? J Clin Endocrinol Metab 1995; 80: 1040-3.
30. REZNEK RH, ARMSTRONG P. Imaging in endocrinology: The adrenal gland. Clin Endocrinol 1994: 40: 561-76.
31. ROSSI G, SACCHETTO A, PAVAN E, PALATINI P, GRANIERO GR, CANALI C, PESINA AC. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997; 95: 1471-8.
32. YOUNG M, FULLERTON M, DILLEY R, FUNDER J. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994; 93: 2578-83.